Roche (OTCMKTS:RHHBY) Stock Crosses Above Fifty Day Moving Average – Should You Sell?

Roche Holding AG (OTCMKTS:RHHBY)’s share price crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $52.13 and traded as high as $57.57. Roche shares last traded at $57.26, with a volume of 1,356,317 shares.

Analyst Upgrades and Downgrades

RHHBY has been the subject of several analyst reports. Zacks Research cut Roche from a “hold” rating to a “strong sell” rating in a report on Tuesday, July 14th. Morgan Stanley raised shares of Roche from an “equal weight” rating to an “overweight” rating and set a $63.00 price objective on the stock in a report on Friday. Finally, HSBC cut shares of Roche from a “buy” rating to a “hold” rating in a research note on Monday, July 6th. Five research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Roche currently has a consensus rating of “Hold” and an average target price of $60.00.

Roche Stock Performance

The company has a current ratio of 1.38, a quick ratio of 1.12 and a debt-to-equity ratio of 0.72. The company has a fifty day moving average price of $52.13 and a two-hundred day moving average price of $52.89.

Institutional Investors Weigh In On Roche

Several hedge funds and other institutional investors have recently bought and sold shares of RHHBY. McIlrath & Eck LLC acquired a new stake in shares of Roche during the 1st quarter worth approximately $39,000. Oakworth Capital Inc. grew its stake in shares of Roche by 20.8% in the fourth quarter. Oakworth Capital Inc. now owns 1,658 shares of the company’s stock valued at $86,000 after buying an additional 285 shares in the last quarter. Atlas Capital Advisors Inc. purchased a new stake in Roche during the fourth quarter worth about $192,000. Pinnacle Wealth Management Advisory Group LLC purchased a new stake in Roche during the 1st quarter worth approximately $208,000. Finally, Enterprise Financial Services Corp increased its position in shares of Roche by 6.6% during the first quarter. Enterprise Financial Services Corp now owns 5,576 shares of the company’s stock worth $277,000 after acquiring an additional 345 shares during the period.

Roche Company Profile

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.